Your browser doesn't support javascript.
loading
Rare germline variants in ATM are associated with chronic lymphocytic leukemia.
Tiao, G; Improgo, M R; Kasar, S; Poh, W; Kamburov, A; Landau, D-A; Tausch, E; Taylor-Weiner, A; Cibulskis, C; Bahl, S; Fernandes, S M; Hoang, K; Rheinbay, E; Kim, H T; Bahlo, J; Robrecht, S; Fischer, K; Hallek, M; Gabriel, S; Lander, E S; Stilgenbauer, S; Wu, C J; Kiezun, A; Getz, G; Brown, J R.
Affiliation
  • Tiao G; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Improgo MR; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Kasar S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Poh W; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Kamburov A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Landau DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Tausch E; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Taylor-Weiner A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Cibulskis C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Bahl S; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Fernandes SM; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Hoang K; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Rheinbay E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Kim HT; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Bahlo J; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Robrecht S; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Fischer K; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Hallek M; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Gabriel S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Lander ES; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Stilgenbauer S; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Wu CJ; Department of Computational Biology and Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kiezun A; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany.
  • Getz G; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany.
  • Brown JR; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany.
Leukemia ; 31(10): 2244-2247, 2017 10.
Article in En | MEDLINE | ID: mdl-28652578

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Germ-Line Mutation / Genetic Predisposition to Disease / Ataxia Telangiectasia Mutated Proteins Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Germ-Line Mutation / Genetic Predisposition to Disease / Ataxia Telangiectasia Mutated Proteins Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Document type: Article Affiliation country:
...